Lexicon Pharmaceuticals | LXRX - Loan Capital

Stock Price
1.31
Daily Change
0 0%
Monthly
5.65%
Yearly
66.90%
Q1 Forecast
2.01

Lexicon Pharmaceuticals reported $56.11M in Loan Capital for its fiscal quarter ending in June of 2025.





Loan Capital Change Date
Abbott USD 11.6B 1.33B Sep/2025
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Akebia Therapeutics USD 47.64M 579K Sep/2025
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
BioMarin Pharmaceutical USD 596.66M 501K Sep/2025
Coherus Biosciences USD 294.85M 2.33M Mar/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Esperion Therapeutics USD 262.48M 235.95M Jun/2024
Halozyme Therapeutics USD 800.07M 709.03M Sep/2025
Illumina USD 1.49B 496M Dec/2025
Insmed USD 539.72M 21.23M Sep/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 39.44B 30M Dec/2025
Lexicon Pharmaceuticals USD 56.11M 2.54M Jun/2025
MacroGenics USD 70.26M 4K Sep/2025
MannKind USD 303.65M 72.94M Sep/2025
Merck USD 39.97B 6B Sep/2025
Moderna USD 610M 584M Dec/2025
Novartis USD 24.24B 174M Sep/2025
PTC Therapeutics USD 1.84B 298.68M Sep/2025
Puma Biotechnology USD 10.87M 222K Jun/2025
Sarepta Therapeutics USD 1.04B 104.31M Sep/2025
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
Ultragenyx Pharmaceutical USD 763.74M 19.02M Sep/2025
United Therapeutics USD 100M 100M Jun/2024
Vanda Pharmaceuticals USD 3.15M 3.15M Dec/2024